Cargando…
A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of Plasmodium vivax Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic Plasmodium berghei Parasite
Infections with Plasmodium vivax are predominant in the Americas, representing 75% of malaria cases. Previously perceived as benign, malaria vivax is, in fact, a highly debilitating and economically important disease. Considering the high complexity of the malaria parasite life cycle, it has been hy...
Autores principales: | Lima, Luciana C., Marques, Rodolfo F., Gimenez, Alba Marina, Françoso, Katia S., Aliprandini, Eduardo, Camargo, Tarsila M., Aguiar, Anna Caroline C., Pereira, Dhelio B., Renia, Laurent, Amino, Rogerio, Soares, Irene S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356588/ https://www.ncbi.nlm.nih.gov/pubmed/32560380 http://dx.doi.org/10.3390/microorganisms8060916 |
Ejemplares similares
-
Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
por: de Camargo, Tarsila Mendes, et al.
Publicado: (2018) -
Quantitative characterization of hemozoin in Plasmodium berghei and vivax
por: Pisciotta, John M., et al.
Publicado: (2017) -
CSP—A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by Hepatocytes
por: Balam, Saidou, et al.
Publicado: (2012) -
Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening
por: Fabbri, Camila, et al.
Publicado: (2021) -
Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
por: Bittencourt, Najara Carneiro, et al.
Publicado: (2020)